Angela Cacace

CXO Think Tank: How Can TPD Differentiate Itself in a Maturing Market of Targeted Drugs & Enter the Standard of Care to Deliver Transformative Therapies to Oncology Patients & Beyond

Charting New Frontiers in Targeted Protein Degradation for Oncology & Neurodegenerative Indications